Why Perenti, Pointsbet, ResMed, and Telix shares are rising today

These ASX shares are starting the week in a positive fashion.

| More on:
Arrows pointing upwards with a man pointing his finger at one.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) has started the week in a positive fashion. In afternoon trade, the benchmark index is currently up 0.5% to 7,343.3 points.

Four ASX shares that are climbing more than most today are listed below. Here's why these ASX shares are rising:

Perenti Ltd (ASX: PRN)

The Perenti share price is up 9% to $1.26. Investors have been buying this mining contractor's shares after its UMA joint venture won a major underground mining services contract. UMA has been awarded a new ~$630 million, 60-month contract at the Newmont Subika underground gold mine in Ghana.

Pointsbet Holdings Ltd (ASX: PBH)

The Pointsbet share price is up 17% to $1.82. This sports betting company's shares are rebounding strongly after being sold off on Friday following the release of its quarterly update. Speculation that its North American business could be sold appears to be giving its shares a boost.

ResMed Inc. (ASX: RMD)

The ResMed share price is up 6% to $35.67. A number of brokers have responded very positively to this sleep treatment company's quarterly update from the end of last week. For example, Citi has retained its buy rating and lifted its price target to $40.50 and Macquarie has retained its outperform rating with an improved price target of $38.00.

Telix Pharmaceuticals Ltd (ASX: TLX)

The Telix share price is up 3% to $10.47. This morning, this radiopharmaceuticals company released additional positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx in clear cell renal cell carcinoma. New data confirms its efficacy in masses 2cm or smaller.

Motley Fool contributor James Mickleboro has positions in Telix Pharmaceuticals. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended PointsBet and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended PointsBet. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »